DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Tumor Ablation Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2015 to 2025" report to their offering.
The global tumor ablation market was valued at US$ 396.89 Mn in 2016, and is expected to reach US$ 1,208.93 Mn by 2025, expanding at a CAGR of 13.2% from 2017 to 2025.
Tumor ablation is a minimally invasive procedure that is commonly used in the treatment of tumors of liver, kidney, bone, and lung; special probes are used to burn or freeze tumor without the surgery. Factors such as growing prevalence of different forms of cancer and growing awareness regarding the benefits offered by ablation procedures over conventional surgical procedures are fueling the growth of tumor ablation market globally. For the purpose of study, global tumor ablation market is segmented on the basis of technology such as radiofrequency ablation, microwave ablation, cryoablation and other technologies.
Currently, radiofrequency ablation held largest market share because it is a commonly used method to treat cancer in bone, kidney, liver, lung and prostate. Faster recovery by radiofrequency ablation would influence the growth of radiofrequency ablation market globally. On the basis of treatment, this market is categorized as surgical ablation, laparoscopic ablation and percutaneous ablation.
Boston Scientific Corp
Bvm Medical Limited
Edap Tms S.A
Galil Medical, Inc
Mermaid Medical, Inc
Neuwave Medical, Inc
- Sonacare Medical, Llc
Key Topics Covered:
Chapter 1 Preface
Chapter 2 Executive Summary
Chapter 3 Tumor Ablation Market Analysis
Chapter 4 Global Tumor Ablation Market, by Technology
Chapter 5 Global Tumor Ablation Market, by Treatment
Chapter 6 Global Tumor Ablation Market, by Application
Chapter 7 Global Tumor Ablation Market, by Geography
Chapter 8 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/4gdrqw/global_tumor